Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037791 (4-(Hydroxy-{1-[2-(3,4,5-trimethoxy-phenyl)-benzofu...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037795 (CHEMBL120885 | Furan-2-carboxylic acid hydroxy-[1-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037807 (CHEMBL331626 | N-[1-(2-Butyl-benzofuran-5-yl)-ethy...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037803 (4-{[1-(2-Butyl-benzofuran-5-yl)-ethyl]-hydroxy-car...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037805 (CHEMBL121025 | N-hydroxy-N-[1-[2-(3,4,5-trimethoxy...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037792 (CHEMBL122955 | N-Hydroxy-N-[1-(2-phenyl-benzofuran...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037793 (4-{Hydroxy-[1-(2-phenyl-benzofuran-5-yl)-ethyl]-ca...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037788 (CHEMBL421255 | N-Hydroxy-N-{1-[2-(6-methoxy-naphth...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037801 (4-{[1-(2-Decyl-benzofuran-5-yl)-ethyl]-hydroxy-car...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037789 (CHEMBL332395 | N-Hydroxy-2-methoxy-N-[1-(2-phenyl-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037796 (Acetic acid {hydroxy-[1-(2-phenyl-benzofuran-5-yl)...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037797 (CHEMBL123396 | N-Hydroxy-3,4-dimethoxy-N-[1-(2-phe...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037806 (CHEMBL123177 | Thiophene-2-carboxylic acid hydroxy...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037794 (CHEMBL331060 | N-Hydroxy-N-{1-[2-(3,4,5-trimethoxy...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 310 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50000541 ((+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea |...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 370 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50022683 (CHEMBL418304 | N-[1-(4-Benzyloxy-phenyl)-ethyl]-N-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 370 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037790 (CHEMBL331881 | N-[1-(2-Decyl-benzofuran-5-yl)-ethy...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 410 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037799 (CHEMBL123649 | N-Hydroxy-N-[1-(4-phenethyloxy-phen...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 410 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037798 (CHEMBL121390 | N-hydroxy-N-[1-(2-phinyl-5-benzofur...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 410 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037787 (CHEMBL332814 | N-Hydroxy-N-[1-(2-phenyl-benzofuran...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 490 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50022697 (CHEMBL62114 | N-Hydroxy-N-{1-[4-(1-phenyl-ethoxy)-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037804 (2,N-Dihydroxy-N-[1-(2-phenyl-benzofuran-5-yl)-ethy...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50240513 ((1-Benzoyl-1-naphthalen-1-yl-2-oxo-2-phenyl-ethyl)...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curve | Bioorg Med Chem Lett 5: 1801-1806 (1995) Article DOI: 10.1016/0960-894X(95)00299-9 BindingDB Entry DOI: 10.7270/Q2CC10NQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037802 (CHEMBL120107 | N-Hydroxy-2,6-dimethoxy-N-[1-(2-phe...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50037800 (CHEMBL121555 | N-Hydroxy-N-[1-(2-phenyl-benzofuran...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 4.83E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
R. W. Johnson Pharmaceutical Research Institute Curated by ChEMBL | Assay Description In vitro inhibition of 5-lipoxygenase (5-HETE) derived from the 9000xg supernatant of RBL broken cell assay | J Med Chem 37: 3663-7 (1994) BindingDB Entry DOI: 10.7270/Q27943Q2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50139758 ((2-Naphthalen-2-yl-1-naphthalen-1-yl-2-oxo-ethyl)-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid PDB UniChem Patents Similars | Article | n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curve | Bioorg Med Chem Lett 5: 1801-1806 (1995) Article DOI: 10.1016/0960-894X(95)00299-9 BindingDB Entry DOI: 10.7270/Q2CC10NQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/beta-7 (Homo sapiens (Human)) | BDBM50090113 ((S)-2-(2-Hydroxy-5-nitro-benzylamino)-N-(3-methyl-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceutical Curated by ChEMBL | Assay Description Inhibition of alpha-4 beta7/MAdCAM mediated cell adhesion was evaluated using B-cell lymphoma RPMI 8866 cells | Bioorg Med Chem Lett 10: 1497-9 (2000) BindingDB Entry DOI: 10.7270/Q2DN4493 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50284958 ((2-Biphenyl-4-yl-1-naphthalen-1-yl-ethyl)-phosphon...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 6.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curve | Bioorg Med Chem Lett 5: 1801-1806 (1995) Article DOI: 10.1016/0960-894X(95)00299-9 BindingDB Entry DOI: 10.7270/Q2CC10NQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/beta-7 (Homo sapiens (Human)) | BDBM50090117 ((S)-2-(2-Hydroxy-5-nitro-benzylamino)-3-phenyl-pro...) | PDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 7.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceutical Curated by ChEMBL | Assay Description Inhibition of alpha-4 beta7/MAdCAM mediated cell adhesion was evaluated using B-cell lymphoma RPMI 8866 cells | Bioorg Med Chem Lett 10: 1497-9 (2000) BindingDB Entry DOI: 10.7270/Q2DN4493 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/beta-7 (Homo sapiens (Human)) | BDBM50090108 ((S)-2-(2-Hydroxy-5-nitro-benzylamino)-3-phenyl-pro...) | PDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 7.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceutical Curated by ChEMBL | Assay Description Inhibition of alpha-4 beta7/MAdCAM mediated cell adhesion was evaluated using B-cell lymphoma RPMI 8866 cells | Bioorg Med Chem Lett 10: 1497-9 (2000) BindingDB Entry DOI: 10.7270/Q2DN4493 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50288643 (CHEMBL106132 | [Phenyl-(2-trifluoromethyl-phenyl)-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents | Article | n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphate | Bioorg Med Chem Lett 6: 311-314 (1996) Article DOI: 10.1016/0960-894X(96)00018-2 BindingDB Entry DOI: 10.7270/Q21R6QGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-4/beta-7 (Homo sapiens (Human)) | BDBM50090119 ((S)-2-(2-Hydroxy-5-nitro-benzylamino)-3-phenyl-pro...) | PDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Millennium Pharmaceutical Curated by ChEMBL | Assay Description Inhibition of alpha-4 beta7/MAdCAM mediated cell adhesion was evaluated using B-cell lymphoma RPMI 8866 cells | Bioorg Med Chem Lett 10: 1497-9 (2000) BindingDB Entry DOI: 10.7270/Q2DN4493 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50284955 (CHEMBL416111 | [1-(4-Chloro-benzyl)-2-(4-chloro-ph...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article | n/a | n/a | 9.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curve | Bioorg Med Chem Lett 5: 1801-1806 (1995) Article DOI: 10.1016/0960-894X(95)00299-9 BindingDB Entry DOI: 10.7270/Q2CC10NQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50284954 (CHEMBL53536 | [2-Cyclohexyl-1-(2-methyl-naphthalen...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curve | Bioorg Med Chem Lett 5: 1801-1806 (1995) Article DOI: 10.1016/0960-894X(95)00299-9 BindingDB Entry DOI: 10.7270/Q2CC10NQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50284957 ((2-Cyclohexyl-1-naphthalen-1-yl-ethyl)-phosphonic ...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 1.14E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curve | Bioorg Med Chem Lett 5: 1801-1806 (1995) Article DOI: 10.1016/0960-894X(95)00299-9 BindingDB Entry DOI: 10.7270/Q2CC10NQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B (Homo sapiens (Human)) | BDBM50226906 (CHEMBL30001) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of canine cardiac fraction III cAMP phosphodiesterase (PDE 3) at 1.875 mg/kg intravenous dose | J Med Chem 30: 1421-6 (1987) BindingDB Entry DOI: 10.7270/Q21J9D0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50288649 ((1,3-Diphenyl-propyl)-phosphonic acid | CHEMBL1062...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphate | Bioorg Med Chem Lett 6: 311-314 (1996) Article DOI: 10.1016/0960-894X(96)00018-2 BindingDB Entry DOI: 10.7270/Q21R6QGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50288656 ((Phenyl-m-tolyl-methyl)-phosphonic acid | CHEMBL71...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphate | Bioorg Med Chem Lett 6: 311-314 (1996) Article DOI: 10.1016/0960-894X(96)00018-2 BindingDB Entry DOI: 10.7270/Q21R6QGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B (Homo sapiens (Human)) | BDBM50226909 (CHEMBL31133) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibitory activity against canine cardiac fraction III cyclic AMP phosphodiesterase (PDE III) at 8.75 mg/kg intravenous dose | J Med Chem 30: 1421-6 (1987) BindingDB Entry DOI: 10.7270/Q21J9D0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50288653 (CHEMBL104125 | [(3-Chloro-phenyl)-phenyl-methyl]-p...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphate | Bioorg Med Chem Lett 6: 311-314 (1996) Article DOI: 10.1016/0960-894X(96)00018-2 BindingDB Entry DOI: 10.7270/Q21R6QGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50288651 ((2-Biphenyl-4-yl-1-phenyl-ethyl)-phosphonic acid |...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphate | Bioorg Med Chem Lett 6: 311-314 (1996) Article DOI: 10.1016/0960-894X(96)00018-2 BindingDB Entry DOI: 10.7270/Q21R6QGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B (Homo sapiens (Human)) | BDBM50226910 (Bemarinone) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of canine cardiac fraction III cAMP phosphodiesterase (PDE 3) at 0.875 mg/kg intravenous dose | J Med Chem 30: 1421-6 (1987) BindingDB Entry DOI: 10.7270/Q21J9D0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50288665 (CHEMBL322700 | [(3-Nitro-phenyl)-phenyl-methyl]-ph...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article | n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphate | Bioorg Med Chem Lett 6: 311-314 (1996) Article DOI: 10.1016/0960-894X(96)00018-2 BindingDB Entry DOI: 10.7270/Q21R6QGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B (Homo sapiens (Human)) | BDBM50226908 (CHEMBL30387) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of canine cardiac fraction III cAMP phosphodiesterase (PDE 3) at 1.875 mg/kg intravenous dose | J Med Chem 30: 1421-6 (1987) BindingDB Entry DOI: 10.7270/Q21J9D0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B (Homo sapiens (Human)) | BDBM50226905 (CHEMBL1743762) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | PubMed | n/a | n/a | 1.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibitory activity against canine cardiac fraction III cyclic AMP phosphodiesterase (PDE III) at 8.75 mg/kg intravenous dose | J Med Chem 30: 1421-6 (1987) BindingDB Entry DOI: 10.7270/Q21J9D0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50284959 (CHEMBL300425 | [2-(4-Chloro-phenyl)-1-naphthalen-1...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article | n/a | n/a | 2.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curve | Bioorg Med Chem Lett 5: 1801-1806 (1995) Article DOI: 10.1016/0960-894X(95)00299-9 BindingDB Entry DOI: 10.7270/Q2CC10NQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50284956 ((1-Naphthalen-1-yl-2-phenyl-ethyl)-phosphonic acid...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article | n/a | n/a | 2.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Tested for 50% of inhibition of Osteoclastic acid phosphatase (OAP) activity, determined using dose-response curve | Bioorg Med Chem Lett 5: 1801-1806 (1995) Article DOI: 10.1016/0960-894X(95)00299-9 BindingDB Entry DOI: 10.7270/Q2CC10NQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B (Homo sapiens (Human)) | BDBM50226907 (CHEMBL30636) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 2.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibitory activity against canine cardiac fraction III cyclic AMP phosphodiesterase (PDE III) at 8.75 mg/kg intravenous dose | J Med Chem 30: 1421-6 (1987) BindingDB Entry DOI: 10.7270/Q21J9D0T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prostatic acid phosphatase (Homo sapiens (Human)) | BDBM50288666 ((9H-Xanthen-9-yl)-phosphonic acid | CHEMBL106688) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article | n/a | n/a | 2.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human prostatic acid phosphatase was determined as inhibition of the hydrolysis of tyrosine phosphate | Bioorg Med Chem Lett 6: 311-314 (1996) Article DOI: 10.1016/0960-894X(96)00018-2 BindingDB Entry DOI: 10.7270/Q21R6QGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A/3B (Homo sapiens (Human)) | BDBM50226913 (CHEMBL30542) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibitory activity against canine cardiac fraction III cyclic AMP phosphodiesterase (PDE III) at 8.75 mg/kg intravenous dose | J Med Chem 30: 1421-6 (1987) BindingDB Entry DOI: 10.7270/Q21J9D0T | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 123 total ) | Next | Last >> |